Form 4: Artivion SVP Sells Shares for Tax Obligations

Artivion's SVP of Clinical & MD Affair, Marshall S. Stanton, sold 2,566 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Marshall S. Stanton, SVP, Clinical & MD Affair at Artivion, Inc. (AORT), reported a sale of common stock.
• On November 10, 2025, Stanton sold 2,566 shares of Artivion common stock at a price of $44.619 per share.
• The sale was a non-discretionary "sell to cover" transaction, executed to satisfy tax withholding obligations upon the vesting of restricted stock units.
• Following this transaction, Stanton beneficially owns 61,634 shares of Artivion common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary 'sell to cover' for tax obligations related to RSU vesting. It has a neutral impact on company sentiment as it does not reflect management's discretionary view on the stock's future performance.

Positives

• The transaction was non-discretionary, indicating it was not a voluntary sale based on a change in sentiment towards the company.
• The sale was a result of restricted stock units vesting, which is a standard compensation event for executives.

Future Outlook

NA

Management Comments

• These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations.
• The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Industry Context

NA

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a routine, non-discretionary sale for tax purposes, not indicative of a change in executive confidence.

Key Dates

Recommendation

The reported transaction is a non-discretionary 'sell to cover' to satisfy tax obligations upon the vesting of restricted stock units. This is a routine event and does not signal a change in the reporting person's confidence in the company's future prospects. Therefore, it provides no new information to alter an existing investment thesis, warranting a 'hold' recommendation based solely on this filing.

Keywords

Artivion, AORT, Marshall S. Stanton, SEC Form 4, Insider Trading, Stock Sale, Restricted Stock Units, Tax Withholding, Sell to Cover, Executive Compensation